The requirements for inducing downregulation of α/β T cell receptor (TCR) molecules on naive major histocompatibility complex class I–restricted T cells was investigated with 2C TCR transgenic mice and defined peptides as antigen. Confirming previous results, activation of 2C T cells in response to specific peptides required CD8 expression on the responder cells and was heavily dependent upon costimulation provided by either B7-1 or ICAM-1 on antigen-presenting cells (APC). These stringent requirements did not apply to TCR downregulation. Thus, TCR downregulation seemed to depend solely on TCR/peptide/interaction and did not require either CD8 or B7-1 expression; ICAM-1 potentiated TCR downregulation, but only with limiting doses of peptides. TCR downregulation was most prominent with high affinity peptides and appeared to be neither obligatory nor sufficient for T cell activation. In marked contrast to T cell activation, TCR downregulation was resistant to various metabolic inhibitors. The biological significance of TCR downregulation is unclear, but could be a device for protecting T cells against excessive signaling.
Skip Nav Destination
Article navigation
17 February 1997
Article|
February 17 1997
Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T Cells
Zeling Cai,
Zeling Cai
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Hidehiro Kishimoto,
Hidehiro Kishimoto
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Anders Brunmark,
Anders Brunmark
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Michael R. Jackson,
Michael R. Jackson
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Per A. Peterson,
Per A. Peterson
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Jonathan Sprent
Jonathan Sprent
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Search for other works by this author on:
Zeling Cai
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Hidehiro Kishimoto
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Anders Brunmark
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Michael R. Jackson
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Per A. Peterson
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Jonathan Sprent
From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; and ‡R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121
Address correspondence to Jonathan Sprent, Department of Immunology, IMM4, The Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037.
1Abbreviations used in this paper: CCD, cytochalasin D; i, internal; s, surface.
Received:
October 03 1996
Revision Received:
December 13 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (4): 641–652.
Article history
Received:
October 03 1996
Revision Received:
December 13 1996
Citation
Zeling Cai, Hidehiro Kishimoto, Anders Brunmark, Michael R. Jackson, Per A. Peterson, Jonathan Sprent; Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T Cells. J Exp Med 17 February 1997; 185 (4): 641–652. doi: https://doi.org/10.1084/jem.185.4.641
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement